BioSpace News Archive

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced it began dosing patients in a Phase 2 clinical study to evaluate its investigational ready-to-use, fixed-ratio co-formulation of pramlintide and insulin in patients with diabetes.

Oyster Point Pharma, Inc., today announced the appointment of Dan Lochner, MBA as its Chief Financial Officer and John Snisarenko, MBA as Chief Commercial Officer. Mr. Lochner and Mr. Snisarenko join the company’s roster of industry veterans.

Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company dedicated to improving clinical outcomes and enhancing the cost-efficiency of colonoscopy, announced today that Tim Moran, Chief Executive Officer, will present a company overview and update at the Ladenburg Thalmann Healthcare Conference on Tuesday, September 24, 2019 at 10:30 AM ET in New York, NY.

Lily Bioceuticals™, a research-based anti-aging skin care and cosmetics manufacturer announces the launch of BEYOND FLAWLESS™ SECOND SKIN, the first viable 24-hour breathable, water proof, life-like cosmetic synthetic skin to diminish eye bags & wrinkles.

Dr. Rhodes oversees the plan’s medical strategy and the clinical direction of medical services and quality improvements to help ensure the best possible health outcomes for Heritage Health members enrolled with WellCare of Nebraska.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced a multinational distribution agreement with Align Technology, Inc. (NASDAQ: ALGN), for the award-winning iTero Element family of intraoral scanners.

Cerevel Therapeutics, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, will present new data from a Phase 2 clinical trial evaluating tavapadon (formerly PF-06649751) in patients with early-stage Parkinson’s disease at the 2019 International Congress of Parkinson’s Disease and Movement Disorders®, taking place from September 22-26 in Nice, France.

California Life Sciences Association (CLSA), the trade association representing California’s life sciences sector, issued the following statement in response to House Speaker Nancy Pelosi’s drug pricing proposal unveiled today.

On Monday, September 23—the first day of fall—the National Council on Aging (NCOA) is partnering with thousands of educators, caregivers, health and aging professionals, community-based organizations, and older adults across the country to focus on one goal: preventing falls.